Compounds > bosentan anhydrous
Page last updated: 2024-08-26

bosentan anhydrous and Malignant Hypertension

bosentan anhydrous has been researched along with Malignant Hypertension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cumming, AD; Firth, JD; Mullins, JJ; Veniant, MM; Whitworth, CE1
Li, JS; Schiffrin, EL; Schürch, W1

Other Studies

2 other study(ies) available for bosentan anhydrous and Malignant Hypertension

ArticleYear
Endothelin in the kidney in malignant phase hypertension.
    Hypertension (Dallas, Tex. : 1979), 1995, Volume: 26, Issue:6 Pt 1

    Topics: Animals; Autoradiography; Blood Pressure; Bosentan; Disease Susceptibility; Endothelins; Gene Expression; Hypertension; Hypertension, Malignant; Kidney; Male; Mice; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; RNA; RNA, Messenger; Sulfonamides; Swine

1995
Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
    American journal of hypertension, 1996, Volume: 9, Issue:8

    Topics: Animals; Arteries; Blood Pressure; Bosentan; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Hypertension, Malignant; Hypertrophy; Kidney; Organ Size; Rats; Rats, Inbred SHR; Renin; Sulfonamides

1996